BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 52 found
  Current Search:  marinol: 52     

HTML
100%
New Tool in Development to Assess Geriatric Cancer Pain
[Annual Symposium on Advances in Pain Research] Eastman, Peggy BETHESDA, MD-As the population ages and the number of older people living with cancer increases, so too will the number of older people living with cancer pain, necessitating new...
Oncology Times:  Jul 21 2008 11:42PM
Matching: marinol
Find similar documents
HTML
100%
Big Pharma Is in a Frenzy to Bring Cannabis-Based
The US government's longstanding denial of medical marijuana research and use is an irrational and morally bankrupt public policy.

On this point, few Americans disagree.

As for the question of 'why' federal officials maintain this...

Media Awareness Project:  Jul 9 2008 5:26AM
Matching: marinol
Find similar documents
HTML
100%
Web: Big Pharma Is in a Frenzy to Bring Cannabis-Based
BIG PHARMA IS IN A FRENZY TO BRING CANNABIS-BASED MEDICINES TO MARKET The US government's longstanding denial of medical marijuana research and use is an irrational and morally bankrupt public policy.

On this point, few Americans disagree....

Media Awareness Project:  Jul 8 2008 3:15AM
Matching: marinol
Find similar documents
HTML
100%
Big Pharma Is in a Frenzy to Bring Cannabis-Based Medicines to Market
While the the American Medical Association claims pot has no medical value, Big Pharma is busy getting patents for marijuana products.

Tools Share and save this post: Also in DrugReporter Bruce Mirken David Borden Amy Turner Jennifer Kern...

AlterNet.org:  Jul 5 2008 8:21AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharma gets US FDA marketing nod for generic Marinol
Par Pharmaceutical Companies, Inc.

has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for dronabinol, a generic version of Solvay Pharmaceutical's Marinol, a CIII controlled...

PharmaBiz:  Jul 2 2008 6:54AM
Matching: marinol
Find similar documents
HTML
100%
Watson launches generic Marinol capsules
Watson Pharmaceuticals, Inc.

(WPI), a leading specialty pharmaceutical company, announced that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and...

PharmaBiz:  Jul 1 2008 6:05AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceuticals Gets FDA Approval For Generic Chemotherapy Side Effect Treatment
(FinancialWire) Par Pharmaceutical Cos.

(NYSE: PRX) has received approval from the Food and Drug Administration for its generic version of Solvay Pharmaceutical's chemotherapy side effect treatment.

The drug, called Marinol, is...

Calibre Macro World:  Jul 1 2008 2:11PM
Matching: marinol
Find similar documents
HTML
100%
Watson Pharmaceuticals Inc ships generic MARINOL capsules
Watson Pharmaceuticals Inc (NYSE: WPI), a speciality pharmaceutical company, said on 30 June that the company has entered into a supply agreement with Solvay Pharmaceuticals Inc for the former's generic dronabinol in the 2.5, 5 and 10 mg...
M2:  Jul 1 2008 5:04PM
Matching: marinol
Find similar documents
HTML
100%
Watson introduces generic Marinol capsules
Dronabinol is the generic version of Solvay Pharmaceuticals's Marinol CIII capsules, indicated to treat nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional...
Pharmaceutical Business Review:  Jul 1 2008 4:47AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.

today announced that it has received final approval from the U.S.

Food and Drug...

KRON4:  Jul 1 2008 8:40AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.

today announced that it has received final approval from the U.S.

Food and Drug...

KOTA Territory News:  Jul 1 2008 7:44AM
Matching: marinol
Find similar documents
HTML
100%
Generic Version of Marinol Launched
but forget your password, you can request it be sent to you by email.

Generic Version of Marinol Launched.

PT Community:  Jul 1 2008 5:52AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical shares rise on FDA approval for generic chemotherapy side effect drug
- 8:10 p.m.

NEW YORK (AP) - Par Pharmaceutical Cos.

shares rose Monday after the company said the Food and Drug Administration approved its generic version of Solvay Pharmaceutical's chemotherapy side effect treatment.

Shares of...

Canadian Business Magazine:  Jul 1 2008 12:29AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.

today announced that it has received final approval from the U.S.

Food and Drug...

KLFY:  Jul 1 2008 12:15AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical gets Final Approval to Market Generic Marinol CIII Capsules - Quick Facts
(RTTNews) - Par Pharmaceutical Companies Inc.

(PRX: News, Chart, Quote ) announced that it has received final approval from the U.S.

Food and Drug Administration for its Abbreviated New Drug Application for dronabinol, a generic version...

RTTNews.com:  Jun 30 2008 6:41PM
Matching: marinol
Find similar documents
HTML
100%
Par Pharma gets final FDA approval to market generic Marinol
SAN FRANCISCO (Thomson Financial) - Par Pharmaceutical Cos.

said Monday it has received final approval from the Food and Drug Administration to market dronabinol, a generic version of Solvay Pharmaceutical's Marinol, for the...

Interactive Investor International:  Jun 30 2008 6:34PM
Matching: marinol
Find similar documents
HTML
100%
Par Pharma gets final FDA approval to market generic Marinol
SAN FRANCISCO (Thomson Financial) - Par Pharmaceutical Cos.

(News) said Monday it has received final approval from the Food and Drug Administration to market dronabinol, a generic version of Solvay Pharmaceutical's Marinol, for the...

FinanzNachrichten.de:  Jun 30 2008 6:56PM
Matching: marinol
Find similar documents
HTML
100%
Par Pharma gets final FDA approval to market generic Marinol
SAN FRANCISCO (Thomson Financial) - Par Pharmaceutical Cos.

said Monday it has received final approval from the Food and Drug Administration to market dronabinol, a generic version of Solvay Pharmaceutical's Marinol, for the...

Sharewatch:  Jun 30 2008 6:17PM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical (PRX) Receives FDA Approval for Generic Marinol
Par Pharmaceutical Companies, Inc.

(NYSE: PRX) has received final approval from the U.S.

Food and Drug Administration (FDA) for its Abbreviated New Drug Application for dronabinol, a generic version of Solvay Pharmaceutical's Marinol,...

Street Insider:  Jun 30 2008 6:46PM
Matching: marinol
Find similar documents
HTML
100%
Watson Pharma launches generic nausea drug
Branded and generic drug maker Watson Pharmaceutical Inc.

said Monday it launched a generic version of Solvay SA's Marinol, which treats chemotherapy-induced nausea.

Marinol is also approved to treat anorexia associated with...

Forbes.com:  Jun 30 2008 4:43PM
Matching: marinol
Find similar documents
HTML
100%
Watson Pharma launches generic nausea drug
CORONA, Calif.

- Branded and generic drug maker Watson Pharmaceutical Inc.

said Monday it launched a generic version of Solvay SA's Marinol, which treats chemotherapy-induced nausea.

Marinol is also approved to treat...

CNBC:  Jun 30 2008 4:16PM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical Receives Final Approval to Market Generic Marinol CIII (Dronabinol) Capsules
Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30, 2008 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.

today announced that it has received final approval from the U.S.

Food and...

Pharma Live:  Jun 30 2008 7:53PM
Matching: marinol
Find similar documents
HTML
100%
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.

(NYSE: PRX - News) today announced that it has received final approval from the U.S.

Food and Drug Administration for its Abbreviated New Drug...

Yahoo! Canada:  Jun 30 2008 6:19PM
Matching: marinol
Find similar documents
HTML
100%
Watson Pharmaceuticals launches generic version of dronabinol
Watson Pharmaceuticals, Inc.has announced that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily dosage strengths.

Dronabinol is...

News-Medical.Net:  Jun 30 2008 8:44AM
Matching: marinol
Find similar documents
HTML
100%
Par Pharma gets final FDA approval to market generic Marinol
Annual U.S.

sales of Marinol are roughly $190 million, Par said, citing IMS Health data.

The Woodcliff, N.J.-based company will begin shipping all strengths of dronabinol soft gel capsules immediately.

Under the terms of an...

TradingMarkets:  Jun 30 2008 6:37PM
Matching: marinol
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.